Brugada Syndrome Clinical Trial
Official title:
Imaging and Risk Stratification in the Brugada Syndrome: a Follow-up Study
Although for many years the Brugada syndrome has been labelled as a purely electrical disease in the structurally normal heart, the evolution of imaging techniques has enabled the discovery of subtle morphofunctional alterations in some of the Brugada syndrome patients. We will use new echocardiographic techniques to assess cardiac function in these patients and new parameters will be evaluated for their prognostic value as risk stratificators.
| Status | Recruiting |
| Enrollment | 150 |
| Est. completion date | July 2019 |
| Est. primary completion date | September 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years or older - Diagnosis of Brugada syndrome Exclusion Criteria: - history of pericarditis, ischemic heart disease, cardiomyopathy of any origin, structural heart disease, or any other channelopathy |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | UZ Brussel | Jette | Brussels |
| Lead Sponsor | Collaborator |
|---|---|
| Universitair Ziekenhuis Brussel |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Composed outcome of sudden cardiac death, appropriate ICD shock and witnessed ventricular fibrillation | Sudden cardiac death is death occuring within 24 hours after being seen in a healthy status or within 1 hour after initiation of symptoms. | 6 years | |
| Secondary | Syncope | Loss of consciousness | 6 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05048602 -
Drug-induced Brugada Syndrome Research Database
|
||
| Terminated |
NCT00701077 -
DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome
|
Phase 3 | |
| Recruiting |
NCT03435393 -
Ripple Mapping for Epicardial Mapping of Brugada Syndrome
|
N/A | |
| Active, not recruiting |
NCT02933437 -
The Response To Ajmaline Provocation in Healthy Subjects
|
Phase 2 | |
| Active, not recruiting |
NCT04257994 -
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
|
||
| Recruiting |
NCT05685134 -
Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter Ablation
|
N/A | |
| Recruiting |
NCT04580992 -
Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial
|
||
| Completed |
NCT02641431 -
Epicardial Ablation in Brugada Syndrome
|
N/A | |
| Completed |
NCT03182777 -
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies
|
N/A | |
| Completed |
NCT00292032 -
Registry of Unexplained Cardiac Arrest
|
||
| Completed |
NCT04124237 -
Long Term Monitoring for Risk of Sudden Death
|
||
| Completed |
NCT02344277 -
Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
|
||
| Completed |
NCT04650009 -
Physical Activity in Children With Inherited Cardiac Diseases
|
||
| Recruiting |
NCT04808193 -
European Perioperative Brugada Survey
|
N/A | |
| Recruiting |
NCT03491475 -
Echocardiography During Ajmaline Test
|
||
| Recruiting |
NCT05521451 -
Clinical Cohort Study - TRUST
|
||
| Completed |
NCT00702117 -
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
|
Phase 4 | |
| Recruiting |
NCT02704416 -
Ablation in Brugada Syndrome for the Prevention of VF
|
N/A | |
| Recruiting |
NCT03775954 -
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
|
||
| Completed |
NCT04420078 -
Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
|